Calcagno A - Search Results

1

Antiviral activity of maraviroc plus mirtazapine in a low-risk HIV-negative patient with progressive multifocal leukoencephalopathy.

Scabini S, Trunfio M, Pirriatore V, Imperiale D, Audagnotto S, Bertucci R, Ghisetti V, Cinnirella G, Cistaro A, Perna M, Calcagno A, Di Perri G. Scabini S, et al. Among authors: calcagno a. Infez Med. 2018 Jun 1;26(2):160-163. Infez Med. 2018. PMID: 29932090 Free article.

2

[Clinical pharmacology of nucleoside and nucleotide reverse transcriptase inhibitors].

Bonora S, Calcagno A, Gonzalez de Requena D, Bargiacchi O, Di Perri G. Bonora S, et al. Among authors: calcagno a. Infez Med. 2006 Jun;14(2):61-70. Infez Med. 2006. PMID: 16891850 Free article. Review. Italian.

3

Unexpected drug-drug interaction between tipranavir/ritonavir and enfuvirtide.

González de Requena D, Calcagno A, Bonora S, Ladetto L, D'Avolio A, Sciandra M, Siccardi M, Bargiacchi O, Sinicco A, Di Perri G. González de Requena D, et al. Among authors: calcagno a. AIDS. 2006 Oct 3;20(15):1977-9. doi: 10.1097/01.aids.0000247121.19951.fa. AIDS. 2006. PMID: 16988521

4

Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus.

Aguilar Marucco D, Veronese L, de Requena DG, Bonora S, Calcagno A, Cavecchia I, Sinicco A, De Rosa FG, Cariti G, Di Perri G. Aguilar Marucco D, et al. Among authors: calcagno a. J Antimicrob Chemother. 2007 Mar;59(3):565-8. doi: 10.1093/jac/dkl497. Epub 2007 Jan 9. J Antimicrob Chemother. 2007. PMID: 17213263

5

Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients.

de Requena DG, Bonora S, Castagna A, Hasson H, Marucco DA, D'Avolio A, Sciandra M, Trentini L, Calcagno A, Lazzarin A, Di Perri G. de Requena DG, et al. Among authors: calcagno a. J Antimicrob Chemother. 2008 Aug;62(2):384-7. doi: 10.1093/jac/dkn192. Epub 2008 May 16. J Antimicrob Chemother. 2008. PMID: 18487231

6

Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins.

Bonora S, Mondo A, Trentini L, Calcagno A, Lucchini A, Di Perri G. Bonora S, et al. Among authors: calcagno a. J Infect. 2008 Jul;57(1):78-81. doi: 10.1016/j.jinf.2008.05.005. Epub 2008 Jun 11. J Infect. 2008. PMID: 18550175

7

Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation.

Bonora S, Nicastri E, Calcagno A, Gonzalez de Requena D, D'Ettorre G, Sarmati L, Palmisano L, Vullo V, Di Perri G, Andreoni M. Bonora S, et al. Among authors: calcagno a. J Med Virol. 2009 Mar;81(3):400-5. doi: 10.1002/jmv.21405. J Med Virol. 2009. PMID: 19152404

8

[HIV infection: treatment of naive patients].

Bonora S, Calcagno A, Di Perri G. Bonora S, et al. Among authors: calcagno a. Infez Med. 2009 Jun;17(2):69-81. Infez Med. 2009. PMID: 19602919 Free article. Review. Italian.

9

Raltegravir penetration in the cerebrospinal fluid of HIV-positive patients.

Calcagno A, Bonora S, Bertucci R, Lucchini A, D'Avolio A, Di Perri G. Calcagno A, et al. AIDS. 2010 Mar 27;24(6):931-2. doi: 10.1097/QAD.0b013e3283319954. AIDS. 2010. PMID: 20234194 No abstract available.

10

Is peritoneal fluid a sanctuary site for HIV?

Calcagno A, Rostagno R, Audagnotto S, D'Avolio A, Bonora S, Ghisetti V, Di Perri G. Calcagno A, et al. J Antimicrob Chemother. 2010 Sep;65(9):2052-3. doi: 10.1093/jac/dkq235. Epub 2010 Jun 23. J Antimicrob Chemother. 2010. PMID: 20573660 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

411 results

Search Page